These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10638142)

  • 1. Pathogenesis of alcoholic liver disease: newer mechanisms of injury.
    Crabb DW
    Keio J Med; 1999 Dec; 48(4):184-8. PubMed ID: 10638142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
    Nagata K; Suzuki H; Sakaguchi S
    J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alcoholic liver disease].
    Waluga M; Hartleb M
    Wiad Lek; 2003; 56(1-2):61-70. PubMed ID: 12901271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of alcohol-induced liver injury. An Update.
    Surrenti C; Galli M
    Minerva Gastroenterol Dietol; 2003 Jun; 49(2):95-105. PubMed ID: 16481976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.
    Mandrekar P; Ambade A; Lim A; Szabo G; Catalano D
    Hepatology; 2011 Dec; 54(6):2185-97. PubMed ID: 21826694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease.
    Bautista AP
    J Gastroenterol Hepatol; 2000 Apr; 15(4):349-56. PubMed ID: 10824877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
    Ceni E; Mello T; Galli A
    World J Gastroenterol; 2014 Dec; 20(47):17756-72. PubMed ID: 25548474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
    Lieber CS
    Alcohol; 2004 Aug; 34(1):9-19. PubMed ID: 15670660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin.
    Thurman RG
    Am J Physiol; 1998 Oct; 275(4):G605-11. PubMed ID: 9756487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.
    Reeves HL; Burt AD; Wood S; Day CP
    J Hepatol; 1996 Nov; 25(5):677-83. PubMed ID: 8938545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression.
    Peng JH; Cui T; Huang F; Chen L; Zhao Y; Xu L; Xu LL; Feng Q; Hu YY
    J Pharmacol Exp Ther; 2013 Mar; 344(3):646-54. PubMed ID: 23277536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D; Coates PM
    Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury.
    Enomoto N; Ikejima K; Bradford BU; Rivera CA; Kono H; Goto M; Yamashina S; Schemmer P; Kitamura T; Oide H; Takei Y; Hirose M; Shimizu H; Miyazaki A; Brenner DA; Sato N; Thurman RG
    J Gastroenterol Hepatol; 2000 Mar; 15 Suppl():D20-5. PubMed ID: 10759216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ethanol changes sensitivity of Kupffer cells to endotoxin].
    Yamashina S; Ikejima K; Enomoto N; Takei Y; Sato N
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):415-24. PubMed ID: 14639920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
    Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
    J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
    Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
    Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcoholic liver disease: pathogenesis and new therapeutic targets.
    Gao B; Bataller R
    Gastroenterology; 2011 Nov; 141(5):1572-85. PubMed ID: 21920463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of iron in alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D; Salin M
    Alcohol; 2003 Jun; 30(2):93-7. PubMed ID: 12957291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-related liver injury due to alcohol involves activation of Kupffer cells by endotoxin.
    Thurman RG
    Can J Gastroenterol; 2000 Nov; 14 Suppl D():129D-135D. PubMed ID: 11110625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.